Agenda highlights include:
Preparing for entry into emerging sourcing hot-spots
Fast-tracking the supplier identification and auditing process to increase speed to market
Actively managing supplier relationships to maximise value
Building water tight intellectual property protection strategies to secure assets
Navigating the complexities of both European and emerging market regulations to ensure compliance across the supply chain
|
Key speakers include:
Giles Breault, Chief Procurement Officer, Novartis Pharmaceuticals
Vanessa Cooke, Vice President, Global Head Strategic Sourcing R&D Services, Bayer HealthCare
Arnulf Heubner, EFCG Chairman of Pharmaceutical Business Committee, Merck KGaA
Jane Vougioukas, Director of Strategic Spend, GlaxoSmithKline
Jerry Davis, Director of Purchasing/ Supplier Management, Baxter Healthcare Corporation
Colin Craig, Associate Director, Global Technical Operations Group, AstraZeneca
Howard Rosenberg, previously Group IP/API Strategy Director for Merck Generics, Mylan Inc.
|